Internal Medicine, Pulmonary Disease · West Columbia, SC
NPI
1326026287
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2728 Sunset Blvd Ste 104
West Columbia, SC, 29169
Phone (803) 256-0464
Groups this clinician bills Medicare through
Medicare paid, 2024
$265K
5,448 services
Medicare patients, 2024
1,805
Average age 75
Drug cost, 2024
$2.9M
7,345 prescriptions
Company payments, 2025
$1,345
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael C Marshall was code 94375 (pulmonary function testing), 996 times for 933 patients. In total Michael C Marshall billed 5,448 services in 40 codes, and Medicare paid $265K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 94375 Pulmonary Function Testing | Office | 996 | 933 | $25.80 | $26K |
| 99214 Office E&M - Established | Office | 952 | 783 | $87.25 | $83K |
| 71046 X-ray - Chest | Office | 604 | 577 | $22.13 | $13K |
| 99213 Office E&M - Established | Office | 561 | 532 | $56.22 | $32K |
| 94729 Pulmonary Function Testing | Office | 263 | 261 | $38.04 | $10K |
| 94726 Pulmonary Function Testing | Office | 249 | 246 | $38.86 | $9,676 |
| 99204 Office E&M - New | Office | 242 | 242 | $111.72 | $27K |
| 95012 Pulmonary | Office | 191 | 182 | $13.00 | $2,483 |
| G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 178 | 175 | $42.73 | $7,607 |
| 94618 Pulmonary Function Testing | Office | 171 | 170 | $22.93 | $3,922 |
| 99203 Office E&M - New | Office | 98 | 98 | $73.81 | $7,233 |
| 36415 Venipuncture Blood Collection | Office | 66 | 63 | $8.49 | $560 |
| 94060 Pulmonary Function Testing | Office | 64 | 64 | $25.50 | $1,632 |
| 95811 Sleep Study | Facility | 47 | 44 | $80.30 | $3,774 |
| 71045 X-ray - Chest | Office | 43 | 39 | $17.33 | $745 |
By year: 2022 $287K for 6,003 services; 2023 $299K for 6,050 services; 2024 $265K for 5,448 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 66 | 63 | $8.49 | $560 |
| 36600 General Laboratory | 36 | 36 | $17.96 | $647 |
| 82803 Clinical Chemistry | 35 | 35 | $24.82 | $869 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael C Marshall prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 1,208 prescriptions and refills. In total Michael C Marshall wrote 7,345 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,208 | 1,443 | 475 | $38K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 815 | 1,053 | 191 | $661K |
| Prednisone Generic | 502 | 663 | 338 | $1,773 |
| Montelukast Sodium Generic | 501 | 1,212 | 162 | $6,257 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 436 | 524 | 110 | $321K |
| Breo Ellipta Fluticasone/Vilanterol | 393 | 592 | 96 | $227K |
| Spiriva Respimat Tiotropium Bromide | 346 | 477 | 68 | $241K |
| Symbicort Budesonide/Formoterol Fumarate | 244 | 358 | 71 | $78K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 204 | 273 | 54 | $48K |
| Fluticasone Propionate Generic | 186 | 336 | 85 | $3,026 |
| Arnuity Ellipta Fluticasone Furoate | 162 | 210 | 36 | $51K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 143 | 183 | 42 | $22K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 135 | 180 | 48 | $32K |
| Advair Hfa Fluticasone Propion/Salmeterol | 121 | 160 | 33 | $58K |
| Qvar Redihaler Beclomethasone Dipropionate | 118 | 154 | 35 | $38K |
Brand drugs: 4,262 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael C Marshall $1,345 ($1,345 in general payments such as food, travel and fees) from 19 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $356.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 17 | $356 |
| GlaxoSmithKline, LLC. GSK | 16 | $265 |
| Genzyme Corporation SNY | 6 | $176 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $99.07 |
| Verona Pharma, Inc. VRNA | 4 | $75.43 |
| Amgen Inc. AMGN | 2 | $50.8 |
| ANI Pharmaceuticals, Inc. ANIP | 2 | $42.04 |
| United Therapeutics Corporation UTHR | 2 | $39.81 |
| Viatris Specialty LLC | 2 | $35.99 |
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $29.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.